First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Clinical trial NCT05768139 · RECRUITING
Trial details
- NCT number
- NCT05768139
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2030-07-01
- Enrollment
- 880
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.